Page 35 - Test PDF v5
P. 35
« Back to Contents CERVICAL CANCER
LiFE re
Literature for ENYGO
Cervical pre-invasive disease (diagnosis, management)
Relevant articles retrieved Nov 2015 - Feb 2016
No Title Authors Journal Link to abstract
Acta Cytol.
1 Multiple Human Papilloma Virus Infections and Their Impact on the Develop- Salazar KL et al. Sci Rep. http://www.karger.com/Article/
ment of High-Risk Cervical Lesions. Int J Cancer. FullText/442512
Int J Cancer.
2 Cervical intraepithelial neoplasia disease progression is associated with Mitra A et al. Am J Obstet Gynecol. http://www.ncbi.nlm.nih.gov/pmc/
increased vaginal microbiome diversity. Int J Gynaecol Obstet. articles/PMC4648063/
Cancer Cytopathol.
3 Evaluating HPV negative CIN2+ in the ATHENA trial. Petry KU et al. BMJ. http://www.ncbi.nlm.nih.gov/
pubmed/26851121
4 Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions Herweijer E et al.
by age at vaccination: A population-based study. http://www.ncbi.nlm.nih.gov/
pubmed/26856527
5 Impact of Human Papillomavirus (HPV) 16 and 18 Vaccination on Prevalent Hildesheim A et al.
Infections and Rates of Cervical Lesions After Excisional Treatment. http://www.ncbi.nlm.nih.gov/
pubmed/26892991
6 Systematic reviews and meta-analyses of the accuracy of HPV tests, visual Mustafa RA
inspection with acetic acid, cytology, and colposcopy. http://www.ncbi.nlm.nih.gov/
pubmed/26851054
7 Clinical performance of the Food and Drug Administration-Approved high-risk Zhou H et al.
HPV test for the detection of high-grade cervicovaginal lesions. http://www.ncbi.nlm.nih.gov/
pubmed/26774025
8 Risk of invasive cervical cancer after atypical glandular cells in cervical Wang J et al.
screening: nationwide cohort study. http://www.bmj.com/content/352/
bmj.i276.long
International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 35